Login to Your Account

NewCo News

Start-Up OncoPep Aims to Head Myeloma Off at Pass

By Anette Breindl
Science Editor

Friday, March 9, 2012
Smoldering multiple myeloma is something of a quandary for doctors. Individuals with the condition have an overall risk of 10 percent per year of progressing to outright myeloma, which is a cancer of the plasma cells.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription